Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study

BACKGROUND: Drug-induced liver injury (DILI) is a common complication of tuberculosis treatment. We utilised data from the REMoxTB clinical trial to describe the incidence of predisposing factors and the natural history in patients with liver enzyme levels elevated in response to tuberculosis treatm...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Med
Autors principals: Tweed, Conor Duncan, Wills, Genevieve Helen, Crook, Angela M., Dawson, Rodney, Diacon, Andreas H., Louw, Cheryl E., McHugh, Timothy D., Mendel, Carl, Meredith, Sarah, Mohapi, Lerato, Murphy, Michael E., Murray, Stephen, Murthy, Sara, Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha, Spigelman, M., Gillespie, S. H.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875008/
https://ncbi.nlm.nih.gov/pubmed/29592805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-018-1033-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars